hypolipidemics (Searle)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehypolipidemics (Searle)
Drug Alias NameSC-66907SC-62945SC-68693SC-70112
ClassificationSmall molecules
Mechanisms of ActionBile acid transport inhibitors
TargetsUpdating
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesG. D. Searle & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A